Sort   by:  
 Page size 
ProteomicsA comprehensive urine proteome database generated from patients with various renal conditions and prostate cancer
A total of 45 urine samples from 5 prostate cancer (PC) patients, 10 renal transplant patients with proven acute rejection (AR), 10 renal transplant patients with stable graft (STA), 10 non-specific proteinuria patients (NS), and 10 healthy individuals (HI), were utilized for global urine proteome p...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2020-11-19 | MSV000086484 | MassIVE
TranscriptomicsSmall RNA-seq from ENCODE/Cold Spring Harbor Lab
This data was generated by ENCODE. If you have questions about the data, contact the submitting laboratory directly (Jonathan Preall jpreall@cshl.edu (Generation 0 Data from Hannon Lab), Carrie Davis davisc@cshl.edu (experimental), Alex Dobin dobin@cshl.edu (computational), Wei Lin wlin@cshl.edu (co...
ORGANISM(S): Homo sapiens 
2010-10-08 | E-GEOD-24565 | biostudies-arrayexpress
ProteomicsSPE optimization for peptide sample preparation for urine peptidomics
Development of a modified solid phase extraction (SPE) approach for improved peptide yield and analysis sensitivity with LC-MS based peptidomics of urine.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2016-08-23 | MSV000080086 | MassIVE
ProteomicsUrinary proPSA isoforms for noninvasive detection of prostate cancer
Prostate cancer (PCa) is the second leading cause of male cancer-related deaths in the United States. Biomarkers for effective early diagnosis and prognosis of prostate cancer are still lacking. The pre-mature forms of prostate specific antigen (PSA), proPSAs, have been shown to be associated with P...
ORGANISM(S): Homo Sapiens 
2025-11-25 | PXD032880 | panorama
GenomicsNational Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments

The Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative seeks to accelerate research in novel marker and drug development, along with understanding the molecular basis of pediatric malignancy, through identification of genomic changes associated with the follo...

phs000218.v5.p1 | EGA
UnknownEffects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial.
Not available
S-EPMC4258222 | biostudies-literature
Sort   by:  
 Page size